Author: Alan Brochstein, CFA

[ad_1] As we described in a previous article, the Global Cannabis Stock Index extended the bounce from November after the huge October loss, rallying 8.1% in December. That index was down 20.1% in 2023, which followed a record decline of 70.4% for 2022. In January, it rallied again, rising 12.2%, but it fell 6.0% in February to 8.55. In this article, we summarize the performance of the other managed indices that New Cannabis Ventures offers to its readers. We discuss the performance of the American Cannabis Operator Index, Ancillary Cannabis Index and Canadian Cannabis LP Index. The one that was quite strong in August and in…

[ad_1] Cannabis stocks, as measured by the Global Cannabis Stock Index,  exploded higher in late August on news that the Department of Health and Human Services had recommended to the DEA that it move cannabis from Schedule 1 to Schedule 3, and the move continued into September. October wiped out the entire rally, and November and December saw the market recover some of the losses. In January, the rally continued as the index rose 12.2%, and it pulled back in February by 6.0% to 8.55: In 2023, Q1 saw a 12.5% decline, and the index dropped 11.8% in Q2. The 22.3%…

[ad_1] The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis companies. This update is our first since late November, and there will be many financial releases very soon. Tracker Rules This data-driven, fact-based tracker will continually update based on new financial filings so that readers can stay up to date. Companies must file with the SEC or SEDAR and be current to be considered for inclusion. When we launched this resource in May 2019, companies with quarterly revenue in excess of US$2.5 million qualified. As the industry has scaled and as…

[ad_1] You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, Cannabis stocks are up so far this year, but this is mainly due to the impressive rally in MSO stocks. The New Cannabis Ventures Global Cannabis Stock Index, which was rebalanced at year-end, currently has 21 members. At year-end, the 7 MSOs were 33.3% of the index. They now account for 42.7% by weight…

[ad_1] February 22, 2024 at 8:49 am Statistics Canada released December retail sales for the country, with cannabis sales increasing from the weak November levels, up 8.2% to C$441.2 million. October was revised lower to C$407.9 million. The sales, which rose 4.7% on a per-day basis, were up just 3.6% from a year ago, down from the 19.8% August growth rate and the lowest annual  growth rate since legalization commenced. In 2022, total sales increased 17.9% to C$4.52 billion, and they  increased 12.3% during 2023. An increase in the number of stores as well as falling flower prices that bring consumers from the…

[ad_1] You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, Cannabis stocks have given up a lot of their early 2024 gains, but they remain up year-to-date by 8.5% and since the prior all-time low set for the NCV Global Cannabis Stock Index in late August and the lower-low set in late October: We warned two weeks ago that MSOs were quite risky. Since…

[ad_1] You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, Canopy Growth reported its fiscal Q3 today. The report was better than what analysts had expected for both revenue and adjusted EBITDA, but the stock fell. Sometimes stocks sell off due to profit-taking, but there is none available for almost all Canopy Growth shareholders. The stock is still above its all-time low set in…

[ad_1] February 9, 2024 at 3:23 pm Michigan cannabis sales for January were were down sequentially after a lift in December. At $242.8 million, sales plunged 13.5% sequentially after setting a record in December. They were up 17.1% from a year earlier, the lowest growth since March 2022: The Michigan Cannabis Regulatory Agency breaks out sales by medical and adult-use, with medical sales falling 77.9% from a year ago to $2.5 million, down 21.9% sequentially, and adult-use sales expanding 22.6% year-over-year to $240.3 million, down 13.2% sequentially: The state breaks out sales by category and provides pricing detail by category, for both…

[ad_1] February 5, 2024 at 12:11 pm New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states. Cannabis sales increased 1.0% sequentially in December after decreasing a small amount in November, according to cannabis data analytics firm BDSA. Looking at a per-day basis, sales increased 4.4% sequentially. In this review, we share the results by state, beginning with the western markets and then concluding with the eastern markets. In total, BDSA estimates that sales across the 11 markets totaled $1.84 billion during the month. Western Markets BDSA provides coverage for Arizona, California, Colorado,…

[ad_1] You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, Last week, we wrote about how the MSOs had posted new highs. This week, they surged again, with the New Cannabis Ventures American Cannabis Operator Index trading to levels not seen in more than a year. In 2022, the year that the index collapsed 65.8%, the index surged during Q4, reaching a closing high…

[ad_1] As we described in a previous article, the Global Cannabis Stock Index extended the bounce from November after the huge October loss, rallying 8.1% in December. That index was down 20.1% in 2023, which followed a record decline of 70.4% for 2022. In January, it rallied again, rising 12.2% to 9.10. In this article, we summarize the performance of the other managed indices that New Cannabis Ventures offers to its readers. We discuss the performance of the American Cannabis Operator Index, Ancillary Cannabis Index and Canadian Cannabis LP Index. The one that was quite strong in August and in September but led the way lower…

[ad_1] January 31, 2024 at 4:25 pm Cannabis stocks, as measured by the Global Cannabis Stock Index,  exploded higher in late August on news that the Department of Health and Human Services had recommended to the DEA that it move cannabis from Schedule 1 to Schedule 3, and the move continued into September. October wiped out the entire rally, and November and December saw the market recover some of the losses. In January, the rally continued as the index rose 12.2% to 9.10: In 2023, Q1 saw a 12.5% decline, and the index dropped 11.8% in Q2. The 22.3% gain in…